Future Market Insights (FMI), in its latest report titled, “Automated Suturing Devices Market: Global Industry Analysis and Opportunity Assessment 2015–2025”, forecasts the global automated suturing devices market revenue to expand at a CAGR of 5.3% during the forecast period (2015–2025). Global automated suturing devices market is estimated to account for US$ 471.0 Mn by the end of 2015, mainly driven by rising number of minimally invasive surgical procedures
Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market during the forecast period. Preference for automated suturing devices over conventional suturing devices during laparoscopic surgeries is a key reason for growth. Further, the device is also preferred by procurement teams at hospitals as it labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices.Rise in geriatric population is a macro factor that’s driving demand for automated suturing devices.
High cost along with negative perception about certain automated suturing devices due tosome FDA-approved devices facing criticism regarding performance can impede the growth of the market.
the impact of COVID-19 on the Automated Suturing Devices market for the year 2020 and beyond. Automated suturing devices are used to hold body tissues together after injury or surgery to enhance the natural healing process. They are commonly used on the skin, internal tissues, organs and blood vessels.
Download a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-579
The report analyses the global automated suturing devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and application. The report also offers information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast.
Region-wise, North America is expected to account for maximum volume share in the global market by 2015and this is expected to double over the forecast period. Western Europe is the second-most lucrative market for automated suturing devices companies. The market revenue in this region is projected to witness a healthy CAGR of 5.6% during the forecast period.
Among product types, disposable automated suturing devices segment is expected to dominate the global automated suturing devices market,followed by the reusable automated suturing devices segment. Increasing prevalence of obesity is expected to boost overall demand for disposable automated suturing devices at a comparatively higher pace.
On the basis of application, automated suturing devices market is segmented into minimally invasive surgeries, open surgeries and trauma cases. Minimally invasive surgeries segment is expected to dominate the overall automated suturing devices market by the end of forecast period. The segment revenue is projected to register fastest growth rate over the forecast period. Open surgeries is projected to be the second fastest growing segment in terms of revenue. Increasing adoption of automated suturing devices among surgeons is fuelling growth of the minimally invasive surgeries segment.
On the basis of end user, global automated suturing devices market has been segmented into hospitals, clinics and ambulatory surgical centers. Hospitals segment is expected to register fastest CAGR in terms of revenue over the forecast period.
Key players profiled in FMI’s market study include Medtronic Plc., Inc., Apollo Endosurgery, LSI Solutions, Inc., Boston Scientific, C. R. Bard, SuturTek Inc. and EndoEvolution, LLC.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/ask-question/rep-gb-579
Major Three Automated Suturing Devices Market Companies:
Medtronic plc is an American Irish-domiciled medical device company that generates the majority of its sales and profits from the U.S. healthcare system but is headquartered in the Republic of Ireland for tax purposes
Apollo Endosurgery is headquartered in the US and operates the business under various segments such as Endo-bariatric, Surgical, and Other. The company enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope.
Boston Scientific is headquartered in the US and offers products through the following business units: Cardiovascular, Rhythm Management, and MedSurg. The company offers Fixate, which is a semi-automatic suturing system. It is designed to secure spinal cord stimulator leads and pain pump catheters.
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/579
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here
Explore Extensive Coverage of FMI’s Industrial Automation & Equipment Landscape
Arthroscopy Procedures and Products Market– Get FMI’s latest growth predictions on the global arthroscopy procedures and products market with exclusive assessment of market dynamics, segmentation, historic, current, and future growth prospects of the global arthroscopy procedures and products market.
Hips and Knees Reconstructive Market– FMI’s comprehensive documentation of the global hips and knees reconstructive market covers segmental analysis, market performance, key trends, and prominent players with their respective market shares, developmental strategies, and business models.
Generic Oncology Drugs Market– Obtain accurate quantitative and qualitative insights on the global generic oncology drugs market encompassing revenue statistics, successful market strategies, competitive landscape, key regions, and growth drivers for 2018-2028 projection period.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in U.S. and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com
Press Release Source: https://www.futuremarketinsights.com/press-release/automated-suturing-devices-market